ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
4,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
5,1,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
6,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
6,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
7,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
8,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
8,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
9,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
10,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
11,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
12,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
12,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
13,1,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
14,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
15,1,Congenital bladder diverticulum,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
15,2,Congenital hydronephrosis,Renal and urinary tract disorders congenital NEC,Renal and urinary tract disorders congenital,Cong,N
16,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
16,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
16,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
16,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
18,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
19,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
19,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
19,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
19,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
20,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
21,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
22,1,Coma hepatic,Coma states,Neurological disorders NEC,Nerv,N
23,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
24,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
25,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
25,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
27,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
27,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
27,3,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
29,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
30,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
30,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
30,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
30,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,5,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
31,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
31,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
33,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
35,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
35,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
35,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
36,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
36,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
37,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
37,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
38,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
38,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
38,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
39,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
39,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
39,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
41,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
41,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
42,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
43,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
44,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
44,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
44,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
45,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
47,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
48,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
49,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
50,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
50,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
51,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
51,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
52,2,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
52,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
54,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
55,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
56,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
57,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,1,Post streptococcal glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
59,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
60,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
60,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
62,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
62,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
63,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
64,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
65,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
65,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
66,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
68,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
69,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
70,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
71,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
73,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
74,2,Hypermagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
75,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
75,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
76,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
77,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
77,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
78,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
79,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
80,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
80,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
80,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
80,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
81,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
81,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
82,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
83,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
84,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
85,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
85,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
85,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
85,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
85,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
87,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
87,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
88,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
89,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
90,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
91,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
92,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
92,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
93,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
93,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
94,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
95,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
97,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
99,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
101,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
101,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
103,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
104,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
104,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
104,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
104,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
105,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
106,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
107,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
108,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
109,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
110,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
112,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
113,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
114,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
115,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
116,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
116,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
116,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
117,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
117,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
117,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
118,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
119,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
120,1,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
121,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
121,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
122,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
124,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
124,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
124,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
124,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
125,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
126,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
127,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
128,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
129,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
130,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,2,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
131,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
132,1,Anaemia folate deficiency,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
132,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
132,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
134,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
134,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
135,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
136,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
137,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
138,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
139,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
140,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
141,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
141,2,Headache,Headaches NEC,Headaches,Nerv,N
141,3,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
141,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
141,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
141,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
141,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
142,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
143,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
144,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
144,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
145,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
146,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
147,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
148,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
149,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
150,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
151,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
152,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
153,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
153,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
154,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
155,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
155,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,1,Chronic cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
156,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
158,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
159,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
161,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
162,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
163,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
164,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
165,1,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
166,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
167,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
167,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
168,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
169,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
170,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
171,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
172,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
173,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
173,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
174,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
174,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
174,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
174,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
175,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
176,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
176,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
176,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
178,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
179,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
179,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
180,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
181,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
181,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
182,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
182,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
182,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
183,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
183,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
184,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
185,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
186,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
186,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
187,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
187,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
188,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
189,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
189,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
191,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,Y
192,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
192,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
192,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
192,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
193,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
194,1,Headache,Headaches NEC,Headaches,Nerv,N
194,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
195,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
195,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
195,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
196,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
197,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
197,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
197,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
198,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
199,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
200,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
200,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
201,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
201,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
201,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
201,5,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
202,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
202,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
202,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
202,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
203,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
203,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
204,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
205,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
205,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
206,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
206,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
207,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
207,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
208,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
209,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
209,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
210,1,Congenital eye disorder,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
210,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
211,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
211,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
212,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
213,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
214,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
215,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
216,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
216,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
216,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
216,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
216,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
217,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
218,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
219,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
219,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
219,3,Hepatitis chronic active,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
219,4,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
219,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
219,6,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
220,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
221,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
221,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
221,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
222,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
223,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
224,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
224,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
224,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
224,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
225,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
225,3,Renal cortical necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
225,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
226,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
227,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
228,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
228,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
230,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
230,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
231,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
232,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
232,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
233,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
234,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
234,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
234,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
234,4,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
235,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
235,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
235,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,Y
237,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
238,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
239,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
239,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
240,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,Y
241,1,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
242,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
243,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
244,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
245,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
246,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
247,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
248,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
249,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
250,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
251,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
252,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
253,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
253,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
253,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
254,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
255,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
256,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
257,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
258,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
258,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
259,1,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
260,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
261,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,2,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
262,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
263,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
264,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
265,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
266,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
267,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
268,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
268,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
269,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
269,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
269,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
269,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
269,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
271,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
272,1,Breast engorgement,Breast signs and symptoms,Breast disorders,Repro,N
273,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
273,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
274,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
274,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
275,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
275,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
277,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
278,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
279,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
280,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
280,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
280,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
280,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
280,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
281,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
282,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
282,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
282,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
282,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
283,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
284,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
285,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
285,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
286,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
286,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
286,4,Primary biliary cholangitis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
286,5,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
287,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
287,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
287,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,4,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
288,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
289,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
289,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
289,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
289,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
290,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,1,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
294,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
295,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
295,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
295,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
296,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
296,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
297,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
297,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
297,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
297,4,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
297,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
298,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
298,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
298,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
298,4,Prothrombin level increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
299,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
299,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,3,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
300,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
301,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
301,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
302,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
302,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
302,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
303,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
304,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
305,1,Headache,Headaches NEC,Headaches,Nerv,N
305,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
306,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
307,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
308,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
308,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
309,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
309,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
310,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
310,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
310,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
311,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
311,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
312,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
313,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
314,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
314,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
315,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
316,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
316,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
317,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
317,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
318,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
319,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
320,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
320,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
322,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
322,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
322,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
323,1,Blood insulin increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
324,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
325,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
326,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
326,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
327,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
327,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,3,Myotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
328,1,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
329,1,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
329,2,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
330,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
331,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
332,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
333,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
333,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
334,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
335,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
336,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
337,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
338,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
339,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
340,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
340,2,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
341,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
342,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
343,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
343,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
343,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
343,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
343,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
344,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
345,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
346,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
347,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
347,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
348,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
349,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
349,2,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
349,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
350,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
350,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
351,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
352,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
352,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
352,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
353,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
354,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
354,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
354,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
355,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
356,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
357,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
357,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
358,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
359,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
360,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
361,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
362,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
363,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
364,1,Hairy cell leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
365,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
365,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
366,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
366,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
366,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
367,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
367,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
367,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
367,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
367,5,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
368,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
369,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
369,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
370,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
371,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
372,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
372,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
372,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
372,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
372,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
373,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
373,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
374,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
375,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
376,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
377,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
378,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
379,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
380,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
381,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
382,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
383,1,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
383,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
384,1,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
385,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
386,1,Enzyme induction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
387,1,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
388,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
389,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
390,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
390,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
391,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
392,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
392,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
393,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
394,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
395,1,Headache,Headaches NEC,Headaches,Nerv,N
395,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
395,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
395,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
396,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
397,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
397,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
397,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
398,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
399,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
400,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
400,2,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
401,1,Plagiocephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
402,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
402,2,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
402,3,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
403,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
403,2,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
403,3,Scrotal ulcer,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
404,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
404,2,Headache,Headaches NEC,Headaches,Nerv,N
404,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
405,1,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
406,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
406,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
407,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
407,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
407,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
408,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
409,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
410,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
411,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
411,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
412,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
413,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
415,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
415,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
416,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
417,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
418,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
418,2,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
418,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
419,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
420,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
421,1,Acne,Acnes,Skin appendage conditions,Skin,N
422,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
423,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
423,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
423,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
423,4,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
423,5,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
423,6,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
424,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
424,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
425,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
425,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
426,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
426,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
427,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
427,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
427,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
428,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
428,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
428,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
429,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
429,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
429,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
429,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
430,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
430,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
430,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
430,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
431,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
431,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
432,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
432,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
432,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
432,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
432,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
433,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
433,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
433,3,Headache,Headaches NEC,Headaches,Nerv,N
433,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
433,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
433,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
434,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
435,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
436,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
436,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
437,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
437,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
438,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
439,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
440,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
441,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
441,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
442,1,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
443,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
443,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
443,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
443,4,Immunoglobulins abnormal,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
443,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
444,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
445,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
445,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
445,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
446,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
447,1,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
448,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
448,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
449,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
450,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
451,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
452,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
453,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
454,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
454,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
454,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
454,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
454,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
454,6,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
454,7,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
454,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
454,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
455,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
456,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
457,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
458,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
458,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
459,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
460,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
461,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
461,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
461,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
461,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
461,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
461,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
462,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
463,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
464,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
465,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
466,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
467,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
467,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
467,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
467,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
467,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
468,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
469,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
469,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
469,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
469,4,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
470,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
470,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
470,3,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
470,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
470,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
471,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
472,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
472,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
472,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
472,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
472,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
472,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
473,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
473,2,Headache,Headaches NEC,Headaches,Nerv,N
473,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
473,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
474,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
474,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
474,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
475,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
475,2,Headache,Headaches NEC,Headaches,Nerv,N
476,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
476,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
477,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
478,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
479,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
479,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
479,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
479,4,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
480,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
480,2,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
481,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
482,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
483,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
484,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
485,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
486,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
486,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
486,4,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
487,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
488,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
489,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
489,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
490,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
490,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
491,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
491,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
491,3,Headache,Headaches NEC,Headaches,Nerv,N
491,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
491,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
492,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
492,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
493,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
493,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
493,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
493,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
494,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
494,2,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
495,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
495,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
496,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
497,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
498,1,Deafness,Hearing losses,Hearing disorders,Ear,N
499,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
500,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
501,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
502,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
502,2,Headache,Headaches NEC,Headaches,Nerv,N
502,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
503,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
504,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
504,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
505,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
505,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
506,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
507,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
508,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
508,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
508,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
509,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
510,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
511,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
512,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
513,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
514,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
515,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
516,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
517,1,Myopathy,Myopathies,Muscle disorders,Musc,N
518,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
518,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
519,1,Prothrombin level increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
520,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
521,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
522,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
523,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
524,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
525,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
526,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
526,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
527,1,Myopathy,Myopathies,Muscle disorders,Musc,N
528,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
529,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
530,1,Myopathy,Myopathies,Muscle disorders,Musc,N
531,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
532,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
533,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
534,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
535,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
536,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
537,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
537,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
538,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
539,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
540,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
540,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
541,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
542,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
543,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
544,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
544,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
544,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
545,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
546,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
546,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
546,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
547,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
548,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
549,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
550,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
551,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
552,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
553,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
553,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
554,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
554,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
555,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
556,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
557,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
558,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
558,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
559,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
560,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
561,1,Headache,Headaches NEC,Headaches,Nerv,N
561,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
561,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
561,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
562,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
563,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
563,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
563,3,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
563,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
564,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
564,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
565,1,Acne,Acnes,Skin appendage conditions,Skin,N
565,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
566,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
566,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
566,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
566,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
567,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
568,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
568,2,Hyperuricaemia,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
569,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
571,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
572,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
572,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
572,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
573,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
573,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
573,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
573,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
573,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
573,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
573,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
573,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
574,1,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
575,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
575,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
576,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
576,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
576,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
576,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
576,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
576,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
577,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
577,2,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
577,3,Encephalocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
578,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
579,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
580,1,Pulmonary valve stenosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
581,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
581,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
582,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
583,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
584,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
584,2,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
585,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
586,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
586,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
586,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
587,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
588,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
588,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
589,1,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
590,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
591,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
591,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
591,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
592,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
593,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
593,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
593,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
594,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
595,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
595,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
596,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
597,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
598,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
599,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
600,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
600,2,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
601,1,Acne,Acnes,Skin appendage conditions,Skin,N
602,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
603,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
603,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
604,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
604,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
604,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
605,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
606,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
607,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
607,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
608,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
609,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
609,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
610,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
610,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
611,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
612,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
613,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
613,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
613,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
613,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
613,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
613,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
614,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
615,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
616,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
617,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
618,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
618,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
618,3,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
618,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
619,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
620,1,Headache,Headaches NEC,Headaches,Nerv,N
620,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
621,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
622,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
622,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
623,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
623,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
623,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
623,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
624,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
625,1,Acne,Acnes,Skin appendage conditions,Skin,N
626,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
626,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
627,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
627,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,Y
627,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
627,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
627,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
627,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
628,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
629,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
629,2,Headache,Headaches NEC,Headaches,Nerv,N
629,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
630,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
630,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
630,3,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
631,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
631,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
631,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
631,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
631,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
631,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
631,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
632,1,Acne,Acnes,Skin appendage conditions,Skin,N
633,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
634,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
635,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
636,1,Coombs negative haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
637,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
637,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
638,1,Acne,Acnes,Skin appendage conditions,Skin,N
639,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
640,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
640,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
640,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
641,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
642,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
643,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
643,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
643,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
644,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
645,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
645,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
646,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
646,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
647,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
648,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
649,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
650,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
651,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
652,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
652,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
652,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
652,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
653,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
653,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
653,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
654,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
655,1,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
655,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
656,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
656,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
656,3,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
656,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
656,5,Jaundice hepatocellular,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
656,6,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
656,7,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
656,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
657,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
658,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
659,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
659,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
660,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
661,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
661,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
661,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
662,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
663,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
663,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
664,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
664,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
664,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
665,1,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
666,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
666,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
667,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
667,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
667,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
667,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
668,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
668,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
668,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
669,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
669,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
669,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
669,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
669,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
670,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
671,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
672,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
672,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
673,1,Deafness,Hearing losses,Hearing disorders,Ear,N
674,1,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
674,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
675,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
675,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
675,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
676,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
676,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
677,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
677,2,Intellectual disability,Intellectual disabilities,Mental impairment disorders,Nerv,N
677,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
678,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
678,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
679,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
680,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
681,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
682,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
682,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
683,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
684,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
684,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
684,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
684,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
684,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
684,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
684,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
685,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
685,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
686,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
686,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
686,3,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
686,4,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
687,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
688,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
688,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
688,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
689,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
689,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
690,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
690,2,Headache,Headaches NEC,Headaches,Nerv,N
690,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
690,4,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
691,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
691,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
692,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
693,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
694,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
695,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
696,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
697,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
697,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
697,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
697,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
698,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
699,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
699,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
700,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
701,1,Developmental hip dysplasia,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
702,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
703,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
703,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
704,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
705,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
706,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
707,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
707,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
708,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
709,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
710,1,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
710,2,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
711,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
711,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
712,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
713,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
714,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
714,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
714,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
714,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
715,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
716,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
716,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
717,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
718,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
719,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
719,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
719,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
719,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
720,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,Y
721,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
721,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
721,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
721,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
722,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
722,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
723,1,Breast engorgement,Breast signs and symptoms,Breast disorders,Repro,N
724,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
724,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
724,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
725,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
725,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
726,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
727,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
728,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
728,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
728,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
729,1,Enzyme induction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
731,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
732,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
733,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
734,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
735,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
735,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
736,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
736,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
737,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
737,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
738,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
739,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
740,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
741,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
742,1,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
743,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
743,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
743,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
744,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
744,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
745,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
746,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
746,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
747,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
748,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
749,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
750,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
750,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
752,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
753,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
753,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
754,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
755,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
756,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
757,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
758,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
759,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
760,1,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
760,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
760,3,Reticulocyte count,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
761,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
761,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
761,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
761,4,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
761,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
762,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
763,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
763,2,Headache,Headaches NEC,Headaches,Nerv,N
763,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
764,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
764,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
764,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
764,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
765,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
765,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
766,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
767,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
767,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
767,3,Glomerulonephritis membranoproliferative,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
767,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
768,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
768,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
769,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
770,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
770,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
770,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
770,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
771,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
772,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
772,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
772,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
772,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
772,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
773,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
774,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
774,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
775,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
775,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
776,1,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
777,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
778,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
778,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
779,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
779,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
779,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
779,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
780,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
781,1,Increased insulin requirement,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
782,1,Koebner phenomenon,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
782,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
783,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
783,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
784,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
784,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
784,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
785,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
785,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
785,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
785,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
786,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
786,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
786,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
787,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
787,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
787,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
787,4,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
788,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
789,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
790,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
790,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
790,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
791,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
792,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
792,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
793,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
794,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
795,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
795,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
796,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
797,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
798,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
799,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
799,2,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
800,1,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
800,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
800,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
801,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
801,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
801,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
801,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
802,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
803,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
803,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
803,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
803,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
804,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
805,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
806,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
807,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
808,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
809,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
809,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
809,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
810,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
811,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
812,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
812,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
812,3,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
812,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
813,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
813,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
813,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
814,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
814,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
814,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
814,4,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
814,5,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
814,6,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
814,7,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
814,8,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
815,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
816,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
816,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
817,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
818,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
818,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
819,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
820,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
820,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
821,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
821,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
822,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
822,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
822,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
823,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
823,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
823,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
824,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
824,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
825,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
825,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
826,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
826,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
827,1,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
828,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
829,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
829,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
829,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
830,1,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
830,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
831,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
831,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
831,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
831,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
832,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
832,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
833,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
833,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
833,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
834,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
834,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
835,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
835,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
836,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
837,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
838,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
838,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
838,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
838,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
839,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
839,2,Myopathy,Myopathies,Muscle disorders,Musc,N
839,3,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
840,1,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
841,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
841,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
842,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
843,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
843,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
844,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
844,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
845,1,Activated partial thromboplastin time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
845,2,Fibrinolysis increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
845,3,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
846,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
847,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
848,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
848,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
848,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
848,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
848,5,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
848,6,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
849,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
850,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
851,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
852,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
852,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
853,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
853,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
853,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,Y
853,4,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
854,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
855,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
856,1,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
857,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
858,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
859,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
859,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
860,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
860,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
861,1,Headache,Headaches NEC,Headaches,Nerv,N
861,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
861,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
861,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
862,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
862,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
863,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
863,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
864,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
864,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
864,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
865,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
866,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
867,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
868,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
868,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
868,3,Headache,Headaches NEC,Headaches,Nerv,N
869,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
869,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
870,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
871,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
872,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
872,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
873,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
873,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
873,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
873,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
874,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
875,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
876,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
877,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
878,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
879,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
880,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
880,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
880,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
880,4,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
881,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
881,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
881,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
882,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
883,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
884,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
885,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
886,1,Deafness,Hearing losses,Hearing disorders,Ear,N
887,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
887,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
887,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
887,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
888,1,Deafness,Hearing losses,Hearing disorders,Ear,N
888,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
888,3,Ear congestion,Ear disorders NEC,Aural disorders NEC,Ear,N
888,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
889,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
889,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
889,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
889,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
890,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
891,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
892,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
893,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
893,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
894,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
894,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
895,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
895,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
895,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
895,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
895,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
895,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
895,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
896,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
896,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
897,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
898,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
898,2,Jaundice hepatocellular,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
898,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
899,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
899,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
899,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
900,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
900,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
900,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
901,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
901,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
902,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
902,2,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
903,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
903,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
903,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
904,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
905,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
906,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
907,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
908,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
908,2,Headache,Headaches NEC,Headaches,Nerv,N
908,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
908,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
908,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
908,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
909,1,CSF test abnormal,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
909,2,HIV infection,Retroviral infections,Viral infectious disorders,Infec,Y
910,1,Headache,Headaches NEC,Headaches,Nerv,N
910,2,Migraine,Migraine headaches,Headaches,Nerv,N
911,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
912,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
912,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
912,3,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
913,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
913,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
914,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
914,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
915,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
915,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
915,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
915,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
916,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
917,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
918,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
918,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
918,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
918,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
918,5,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
919,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
919,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
919,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
919,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
920,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
920,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
921,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
922,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
923,1,Chondrocalcinosis,Crystal arthropathic disorders,Joint disorders,Musc,N
923,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
924,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
924,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
925,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
925,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
925,3,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
925,4,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
925,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
925,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
925,7,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
926,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
927,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
927,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
928,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
928,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
929,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
929,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
930,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
930,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
931,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
931,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
931,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
931,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
932,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
932,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
932,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
932,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
932,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
932,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
933,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
933,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
933,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
933,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
933,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
934,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
934,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
934,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
934,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
934,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
934,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
934,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
934,8,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
934,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
935,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
936,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
936,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
936,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
936,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
936,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
936,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
936,7,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
936,8,Metabolic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
936,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
937,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
937,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
937,3,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
937,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
938,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
938,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
939,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
940,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
940,2,Meningitis tuberculous,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
941,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
941,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
941,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
942,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
943,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
943,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
943,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
943,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
944,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
944,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
944,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
945,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
945,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
946,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
946,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
946,3,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
946,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
947,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
947,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
948,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,2,Induced abortion failed,Induced abortion complications,Procedural related injuries and complications NEC,Inj&P,N
949,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
949,2,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
949,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
949,4,Acid fast bacilli infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
949,5,Bacterial test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
949,6,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
949,7,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
949,8,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
949,9,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
949,10,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
949,11,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
949,12,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
949,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
949,14,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
949,15,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
949,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
949,17,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
949,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
949,19,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
949,20,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
949,21,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
949,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
950,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
950,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
950,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
950,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
951,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
951,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
952,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
952,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
952,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
952,4,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
952,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
953,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
954,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
954,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
955,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
955,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
955,3,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
955,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
955,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
956,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
956,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
957,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
958,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
959,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
959,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
960,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
960,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
960,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
960,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
961,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
962,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
962,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
963,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
963,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,4,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
964,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
965,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
966,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
967,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
968,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
968,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
969,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
969,2,Bladder perforation,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
969,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
969,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
969,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
969,6,Disseminated Bacillus Calmette-Guerin infection,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
969,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
969,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
969,9,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
969,10,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
969,11,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
969,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
969,13,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
970,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
970,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
971,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
972,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
973,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
973,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
973,3,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
974,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
975,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
976,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
977,1,Headache,Headaches NEC,Headaches,Nerv,N
977,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
978,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
978,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
979,1,Headache,Headaches NEC,Headaches,Nerv,N
979,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
979,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
979,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
979,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
979,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
979,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
980,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
981,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
982,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
983,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
983,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
984,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
984,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
985,1,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
985,2,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
985,3,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
986,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
986,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
987,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
988,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
988,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
989,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
989,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
989,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
990,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
990,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
991,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
991,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
991,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
992,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
992,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
993,1,Coagulation time shortened,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
993,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
994,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
994,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
994,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
995,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,3,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
995,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
996,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
996,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
997,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
998,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
999,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1000,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1000,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1001,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1002,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1002,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1002,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1002,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1002,5,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1002,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1003,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1003,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1003,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1003,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1003,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1003,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1004,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1005,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1005,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1006,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
1006,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1006,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1006,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1007,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1007,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1007,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1007,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1008,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1008,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1009,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1010,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1010,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1011,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
1011,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1012,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1012,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1012,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1012,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1013,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1013,2,Headache,Headaches NEC,Headaches,Nerv,N
1013,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1014,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1015,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1016,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1016,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1016,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1016,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1017,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1018,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1018,2,Pregnancy with implant contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1019,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1020,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1021,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1022,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1022,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1022,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1023,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1024,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,2,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1025,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1025,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1026,1,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
1027,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1027,2,Headache,Headaches NEC,Headaches,Nerv,N
1027,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1027,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1027,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1027,6,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
1028,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1029,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1029,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1029,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1029,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1029,6,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1030,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1030,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1030,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1030,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1031,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1032,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1032,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1033,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1034,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1034,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1035,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1035,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1036,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1036,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1036,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1036,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1036,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1037,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1037,2,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
1038,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1039,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1039,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1039,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1040,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1041,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1041,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1041,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1042,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1042,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1042,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1042,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1043,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1043,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1044,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1044,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1044,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1044,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1044,5,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1044,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1044,7,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1044,8,Prothrombin level increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1044,9,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1045,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1045,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1046,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1046,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1047,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1047,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1048,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1048,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1048,3,Hypoprothrombinaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1049,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1049,2,Hypoprothrombinaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1050,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1050,2,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1051,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1051,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1051,3,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1052,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1053,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1053,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1053,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1053,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1053,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1054,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1054,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1055,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1055,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1055,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1055,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1055,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1055,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1055,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1056,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1056,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1056,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1056,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1057,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1058,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1059,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1060,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1060,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1060,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1060,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1060,5,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1061,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1061,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1061,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1061,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1061,5,Food aversion,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1061,6,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1061,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1061,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1061,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1061,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1061,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1061,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1061,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1061,14,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1061,15,Postural orthostatic tachycardia syndrome,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1061,16,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1061,17,Primary biliary cholangitis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1061,18,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1061,19,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1062,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1062,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1062,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1063,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1064,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
1065,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1065,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1065,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1066,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,2,Pregnancy on contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1067,1,Retinal pigmentation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1068,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1068,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1068,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1069,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1069,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1069,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1069,4,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1069,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1069,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1069,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1069,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1069,9,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1069,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1069,11,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1069,12,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1069,13,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1069,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1069,15,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1070,1,Allergy test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
1070,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1071,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1071,2,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1072,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1073,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1073,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1073,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1073,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1073,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1073,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1073,7,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1073,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1073,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1073,10,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1073,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1073,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1074,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1074,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1074,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1074,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1075,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1075,2,Cerebral vasoconstriction,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1075,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1075,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1075,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1075,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1075,7,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1075,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1075,9,Porphyria acute,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
1075,10,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1075,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1075,12,Urine delta aminolevulinate,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1075,13,Urine porphobilinogen increased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1075,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1076,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1077,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1077,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1078,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1078,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1078,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1078,4,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1078,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1078,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1078,7,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1078,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1078,9,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1078,10,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1078,11,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1078,12,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1078,13,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1078,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1078,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1078,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1078,17,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1078,18,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1078,19,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1078,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1079,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1079,2,Paraesthesia mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1080,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1081,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1081,2,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1082,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1082,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1082,3,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1082,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1082,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1082,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1082,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1083,1,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1084,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1084,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1085,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1085,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1085,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1086,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1086,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1086,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1086,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1087,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1087,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1087,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1087,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1087,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1088,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1088,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1088,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1088,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1088,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1088,6,Headache,Headaches NEC,Headaches,Nerv,N
1088,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1088,8,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1088,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1088,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1088,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1088,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1088,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1088,14,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1088,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1088,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1088,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1089,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1090,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1091,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1091,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1091,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1091,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1091,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1091,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1091,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1091,8,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1092,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1092,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1093,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
1093,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1093,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1094,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1094,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1094,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1094,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1094,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1094,6,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1094,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1094,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1094,9,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1094,10,Monocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1094,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
1094,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1094,13,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1095,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1095,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1096,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1096,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1096,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1096,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1097,1,Catheter site discharge,Implant and catheter site reactions,Administration site reactions,Genrl,N
1097,2,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1097,3,On and off phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1097,4,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1097,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1097,6,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1098,1,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
1098,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1098,3,Endocarditis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1098,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1098,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1099,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1099,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1099,3,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1099,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1099,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1100,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1100,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1101,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1101,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1101,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1101,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1101,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1101,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1102,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1102,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1103,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1103,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1103,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1103,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1104,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1105,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1105,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1105,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1105,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1105,5,Headache,Headaches NEC,Headaches,Nerv,N
1105,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1105,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1105,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1105,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1105,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1105,11,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1105,12,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1106,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1107,1,Acne,Acnes,Skin appendage conditions,Skin,N
1107,2,Acne,Acnes,Skin appendage conditions,Skin,N
1107,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1108,1,Antipsychotic drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1108,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1109,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1109,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1110,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1110,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1111,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1112,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1113,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1113,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1113,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1114,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1114,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1115,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1116,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1117,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1117,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1117,3,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1118,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1118,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1118,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1119,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1119,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1119,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1120,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1120,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1120,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1120,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1120,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1121,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1122,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1122,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1122,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1122,4,Headache,Headaches NEC,Headaches,Nerv,N
1122,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1122,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1123,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1123,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1124,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1124,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1124,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1125,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1126,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1126,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1127,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1127,2,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
1127,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1127,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1128,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1129,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1129,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1130,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1131,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1132,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1132,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1132,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1133,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1133,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1134,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1135,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1135,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1135,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1136,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1136,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1136,3,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1137,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1137,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1137,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1137,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1137,5,Normochromic normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1137,6,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1137,7,Vitamin K deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
1138,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1138,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1139,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1139,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1140,1,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1140,2,Loss of proprioception,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1140,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1140,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1141,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1141,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1142,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1142,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1143,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1144,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1144,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1145,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1145,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1146,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1146,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1146,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1146,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1147,1,Meningitis tuberculous,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1147,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1148,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1148,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1148,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1148,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1148,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1148,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1148,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1149,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1149,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1149,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1149,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1149,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1150,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1150,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1150,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1150,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1150,5,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1150,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1151,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1152,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1152,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1153,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1153,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1153,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1153,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1153,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1153,6,Headache,Headaches NEC,Headaches,Nerv,N
1153,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1153,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
1154,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1155,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1155,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1155,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1156,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1156,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1157,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1157,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1157,3,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1157,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1157,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1157,6,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1157,7,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1157,8,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1157,9,Human herpesvirus 7 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1157,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1157,11,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1157,12,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1157,13,Monocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1157,14,Myalgia,Muscle pains,Muscle disorders,Musc,N
1157,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1157,16,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1157,17,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1158,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1158,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1158,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1158,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1158,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1158,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1158,7,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1158,8,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1159,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1160,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1161,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1161,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1161,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1162,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1162,2,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1162,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1163,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1164,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1165,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1165,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1166,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1167,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1167,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1168,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1169,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1169,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1169,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1170,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1170,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1170,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1170,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1171,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1171,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1172,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1173,1,Antipsychotic drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1173,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1173,3,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1174,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1174,2,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1174,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1174,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1175,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1175,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1175,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1175,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1175,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1176,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1176,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1176,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1176,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1176,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1176,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1177,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1177,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1177,3,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1177,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1177,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1177,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1178,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1179,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1179,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1180,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1181,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1181,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1181,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1181,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1181,5,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
1182,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1182,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1182,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1183,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1183,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1184,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1184,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1185,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1186,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1186,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1187,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1187,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1188,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1189,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1189,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1190,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1190,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1190,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1190,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1190,5,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1190,6,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1190,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1190,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1191,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1191,2,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1191,3,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1192,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1192,2,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1192,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1192,4,Septic rash,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1192,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1192,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1193,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1194,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1195,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1196,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1197,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1198,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1199,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1199,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1199,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1200,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1200,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1200,3,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1200,4,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1200,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1201,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1202,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1202,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1203,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1204,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1205,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1205,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1206,1,Acne,Acnes,Skin appendage conditions,Skin,N
1206,2,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1206,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1206,4,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1207,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1208,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1208,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1208,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1209,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1209,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1209,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1210,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1210,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1210,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1210,4,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
1211,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1212,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1212,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1213,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1214,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1215,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1215,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1216,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1217,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1217,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1218,1,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1218,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1218,3,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1218,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1219,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1219,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1219,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1220,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1220,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1221,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1221,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1222,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1223,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1224,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1225,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1226,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1227,1,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1227,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1227,3,Subacute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1228,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1229,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1229,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1230,1,Antipsychotic drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1230,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1230,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1231,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
1232,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1232,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1232,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1233,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1234,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1234,2,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1234,3,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1234,4,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1234,5,Adrenomegaly,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
1234,6,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1234,7,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1234,8,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1234,9,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1234,10,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1234,11,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1234,12,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1234,13,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1234,14,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1234,15,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1234,16,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1234,17,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1234,18,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1234,19,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1234,20,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1234,21,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1234,22,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1234,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1234,24,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1234,25,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1234,26,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1234,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1235,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1235,2,Tubo-ovarian abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1236,1,Acidosis hyperchloraemic,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1236,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1236,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1236,4,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1236,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1237,1,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1237,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1237,3,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1238,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1239,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1239,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1239,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1240,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1240,2,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1240,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1241,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1242,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1242,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1242,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1242,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1242,5,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1242,6,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1242,7,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1242,8,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1242,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1242,10,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1242,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1243,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1243,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1244,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1244,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1244,3,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1244,4,Obsessive-compulsive symptom,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1245,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1246,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1247,1,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1247,2,Headache,Headaches NEC,Headaches,Nerv,N
1247,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1248,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1249,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1250,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1251,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1251,2,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1251,3,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1251,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1251,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1252,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1252,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1252,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1252,4,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1253,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1253,2,Decerebrate posture,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1253,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1253,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1253,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1253,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1253,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1254,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1255,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1256,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1257,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1257,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1257,3,Cholestasis of pregnancy,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1257,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1257,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1257,6,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1257,7,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1257,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1258,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1259,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1260,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1261,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1261,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1261,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1261,4,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1261,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1261,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1262,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
1262,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1262,3,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1262,4,Pseudomembranous colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1262,5,Sigmoidoscopy abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
1263,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1264,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1264,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1264,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1265,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1265,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1266,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1266,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1266,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1266,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1267,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1268,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
1268,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1268,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1268,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1269,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1269,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1269,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1269,4,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1269,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1269,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1270,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1270,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1271,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1271,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1271,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1271,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1271,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1271,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1272,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1272,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1272,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1272,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1272,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1272,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1273,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1274,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1274,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1274,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1275,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1275,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1276,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1276,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1277,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1278,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1278,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1278,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1279,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1280,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1281,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1281,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1281,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1281,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1281,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1282,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1282,2,Anticoagulation drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1282,3,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1282,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1283,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1283,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1284,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1284,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1285,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1285,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1285,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1286,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1286,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1287,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1287,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1288,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1288,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1288,3,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1288,4,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,5,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1288,7,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,8,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,9,Bilirubin conjugated increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,10,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1288,11,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,12,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1288,13,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1288,14,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1288,15,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1288,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1288,17,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1288,18,Headache,Headaches NEC,Headaches,Nerv,N
1288,19,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1288,20,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1288,21,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1288,22,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
1288,23,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,24,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1288,25,Myalgia,Muscle pains,Muscle disorders,Musc,N
1288,26,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1288,27,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1288,28,Protein total increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1288,29,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1288,30,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1288,31,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1288,32,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1288,33,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1288,34,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1289,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1289,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1289,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1289,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1290,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1291,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1292,1,Headache,Headaches NEC,Headaches,Nerv,N
1292,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1292,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1293,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1293,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1294,1,Semen discolouration,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
1295,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1296,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1297,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1298,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1299,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1299,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1299,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1299,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1299,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1299,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1299,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1299,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1299,9,Sopor,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1299,10,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1299,11,Therapy naive,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1299,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1299,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1300,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1300,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1301,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1301,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1301,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1301,4,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1301,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1301,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1301,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1301,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1301,9,Sopor,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1301,10,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1301,11,Therapy naive,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1301,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1301,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1302,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1302,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1302,3,Headache,Headaches NEC,Headaches,Nerv,N
1303,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1303,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1303,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1303,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1304,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1304,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1304,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1304,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1304,5,Nocardia sepsis,Nocardia infections,Bacterial infectious disorders,Infec,N
1304,6,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1305,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1305,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1305,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1305,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1306,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1306,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1307,1,Headache,Headaches NEC,Headaches,Nerv,N
1308,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1309,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1309,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1309,3,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1309,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1309,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1309,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1309,7,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1309,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1309,9,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1309,10,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1309,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1309,12,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1309,13,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1309,14,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1309,15,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1309,16,Liver palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1309,17,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1309,18,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1309,19,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1309,20,Spleen palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1309,21,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1310,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1310,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1310,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1310,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1310,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1311,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1311,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1312,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1312,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1312,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1312,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1312,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1312,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1312,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1313,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1313,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1313,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1313,4,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1313,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1313,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1314,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1314,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1314,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1315,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1315,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1315,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1315,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1315,5,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1315,6,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1315,7,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1315,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1315,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1316,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1316,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1316,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1316,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1316,5,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1316,6,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1316,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1316,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1317,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1318,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1319,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1320,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1320,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1320,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1320,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1320,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1321,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1322,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
1323,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1323,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1324,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1324,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1324,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1324,4,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1324,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1325,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1325,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1325,3,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1325,4,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1326,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1326,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1327,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1327,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1327,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1328,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1328,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1328,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1328,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1328,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1328,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1328,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1328,8,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1328,9,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1328,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1328,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1329,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1329,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1329,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1329,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1329,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1329,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1329,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1329,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1329,9,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1329,10,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1329,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1329,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1329,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1330,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1330,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1331,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1331,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1331,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1332,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1333,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1333,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1333,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1333,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1334,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1335,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1335,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1335,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1335,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1335,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1336,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1337,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1337,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1337,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
1338,1,Hyperaldosteronism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1339,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1339,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1339,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1339,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1339,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1340,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1340,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1340,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1340,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1340,5,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
1341,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1342,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1342,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1343,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1343,2,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1343,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1343,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1343,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1344,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1345,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1345,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1346,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1346,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1346,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1346,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1346,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1346,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1346,7,Headache,Headaches NEC,Headaches,Nerv,N
1346,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1346,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1346,10,Sleep deficit,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
1346,11,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1347,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1347,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1347,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1347,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1348,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1348,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1348,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1348,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1348,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1349,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1350,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1350,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1350,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1350,4,International normalised ratio,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1351,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1351,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1351,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1352,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1352,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1352,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1352,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1352,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1353,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1353,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1353,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1354,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1355,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1356,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1357,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1357,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1357,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1357,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1357,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1358,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1359,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1360,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1360,2,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1360,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1361,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1362,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1362,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1362,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1362,4,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1362,5,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1363,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1363,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1364,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1364,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1365,1,Lip pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1365,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1366,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1366,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1366,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1367,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1368,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1368,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1369,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1369,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1370,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1371,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1372,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1372,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1372,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1372,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1372,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1373,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1373,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1373,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1373,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1373,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1373,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1373,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1373,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1374,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1374,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1374,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1374,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1374,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1375,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1375,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1376,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1377,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1378,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1378,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1378,3,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1378,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1378,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1378,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1378,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1379,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1379,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1379,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1379,4,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1379,5,Jaundice acholuric,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1379,6,Leukoerythroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1379,7,Polychromasia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1379,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1379,9,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1380,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1381,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1381,2,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
1382,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1382,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1383,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1384,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1385,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1386,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1387,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1388,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1388,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1389,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1390,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1390,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1390,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1391,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1391,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1391,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1391,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1391,5,Remission not achieved,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1392,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1392,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1392,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1392,5,Remission not achieved,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1393,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1394,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1395,1,Aspermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
1396,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1396,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1396,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1396,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1397,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1397,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1397,3,Bile duct necrosis,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1397,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1397,5,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1397,6,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1397,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1397,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1397,9,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1397,10,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1397,11,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1397,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1397,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1397,14,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1397,15,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1397,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1397,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1397,18,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1397,19,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1398,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1398,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1399,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1399,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1399,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1399,4,Bile duct necrosis,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1399,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1399,6,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1399,7,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1399,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1399,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1399,10,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1399,11,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1399,12,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1399,13,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1399,14,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1399,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1399,16,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1399,17,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1399,18,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1399,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1399,20,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1399,21,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1399,22,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1400,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1401,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1401,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1401,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1401,4,Bile duct necrosis,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1401,5,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1401,6,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1401,7,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1401,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1401,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1401,10,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1401,11,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1401,12,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1401,13,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1401,14,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1401,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1401,16,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1401,17,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1401,18,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1401,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1401,20,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1401,21,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1401,22,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1402,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1402,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1402,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1402,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1402,5,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1402,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1402,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1402,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1403,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1403,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1403,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1403,4,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1403,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1403,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1403,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1404,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1404,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1405,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1405,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1406,1,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1407,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1407,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1407,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1407,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1408,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1408,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1409,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1409,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1409,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1410,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1410,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1410,3,Temporomandibular pain and dysfunction syndrome,Joint related disorders NEC,Joint disorders,Musc,N
1411,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1411,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1411,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1412,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1412,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1413,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1413,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1414,1,Foetal anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1414,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1414,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1415,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1416,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1416,2,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1416,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1416,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1417,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1417,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1418,1,Metal poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1418,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1419,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1420,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1420,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1421,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1421,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1421,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1422,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1423,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1423,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1423,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1423,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1423,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1423,6,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1423,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1423,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1423,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1423,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1424,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1424,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1425,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1426,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1426,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1427,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1427,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1427,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1427,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1428,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1428,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1428,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1429,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1429,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1430,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1431,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1431,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1432,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1432,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1432,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1434,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1434,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1435,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1436,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1436,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1437,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1438,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1439,1,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
1439,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1439,3,Endocarditis staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1439,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1439,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1440,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1440,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1441,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1442,1,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1443,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1443,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1444,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1444,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1445,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1445,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1446,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1447,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1447,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1448,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1448,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1449,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1449,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1449,3,Bile duct necrosis,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1449,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1449,5,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1449,6,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1449,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1449,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1449,9,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1449,10,Gamma-glutamyltransferase decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1449,11,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1449,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1449,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1449,14,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1449,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1449,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1449,17,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
1449,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1450,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1450,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1450,3,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
1450,4,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1450,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1451,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1452,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
1452,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1453,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1454,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1454,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1454,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1454,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1454,5,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1454,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1454,7,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1455,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1455,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1455,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1455,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1455,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1455,6,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1456,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1456,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1456,3,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1456,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1456,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1456,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1456,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1456,8,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1456,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1457,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1457,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1457,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1457,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1458,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1458,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1458,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1459,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1459,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1459,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1459,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1460,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1460,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1460,3,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1460,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1460,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1460,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1460,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1460,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1461,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1461,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1461,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1462,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1462,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1463,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1463,2,Headache,Headaches NEC,Headaches,Nerv,N
1463,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1463,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1464,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1465,1,Headache,Headaches NEC,Headaches,Nerv,N
1465,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1465,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1466,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1466,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1466,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1466,4,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1466,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1466,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1466,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1466,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1466,9,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1466,10,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
1466,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1467,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1467,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1467,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1468,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1469,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1469,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1469,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1469,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1469,5,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1469,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1470,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1470,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1470,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1471,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1472,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1472,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1473,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1473,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1473,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1473,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1473,5,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1473,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1474,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1474,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1474,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1474,4,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1474,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1474,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1474,7,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1474,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1475,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1475,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1475,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1475,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1476,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1477,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1477,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1478,1,Headache,Headaches NEC,Headaches,Nerv,N
1478,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1478,3,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1479,1,Hyperbilirubinaemia neonatal,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1480,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1481,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1482,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1483,1,False positive investigation result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1484,1,Coagulation test abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1485,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1486,1,Eosinophilic pneumonia acute,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1487,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1487,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1487,3,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1488,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1488,2,Pregnancy test positive,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
1489,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1490,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1490,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1490,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1491,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1492,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1493,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1493,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1493,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1494,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1494,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
1495,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1496,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1496,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1496,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1496,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1497,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1498,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
1498,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1498,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1499,1,Ketonuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1499,2,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
1499,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
1499,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1499,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1499,6,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1499,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1500,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1500,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1501,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
1501,2,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1501,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1501,4,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1502,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1502,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1503,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1504,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1505,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1506,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1507,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1507,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1507,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1507,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1507,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1507,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1508,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1508,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1508,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1508,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1508,5,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1509,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1510,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1511,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1511,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1512,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1512,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1512,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1512,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1512,5,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1513,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1513,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1513,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1513,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1513,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1513,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1513,7,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1514,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1514,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1514,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1514,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1514,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1514,6,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1515,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1516,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1516,2,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1516,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1517,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1517,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1517,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1517,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1518,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1518,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1518,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1518,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1518,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1519,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1519,2,Trichoglossia,Tongue disorders,Tongue conditions,Gastr,N
1520,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1520,2,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1520,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1520,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1521,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1522,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
1522,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1522,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1522,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1522,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1522,6,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1522,7,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
1522,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1522,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1522,10,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1522,11,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1522,12,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1522,13,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1523,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1523,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1524,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1524,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1525,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1526,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1526,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1526,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1526,4,Headache,Headaches NEC,Headaches,Nerv,N
1526,5,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1527,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1528,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1529,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1529,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1529,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1529,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1530,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1530,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1531,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1531,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1532,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1533,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1533,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1534,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1534,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1534,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1535,1,Acquired aminoaciduria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1535,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1535,3,Metabolic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1535,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1536,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1537,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1537,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1537,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1538,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
1538,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1539,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1540,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1540,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1541,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1541,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1542,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1542,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1542,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1542,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1543,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1543,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1544,1,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
1544,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1544,3,Subacute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1545,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1546,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1547,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1547,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1548,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1549,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1550,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1551,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1551,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1552,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1553,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
1554,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1555,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1556,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1556,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1556,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1556,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1557,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1558,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1559,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1559,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1560,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1561,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1561,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1561,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1561,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1562,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1563,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1564,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1565,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1565,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1565,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1565,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1566,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1566,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1567,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1567,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1568,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1568,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1568,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1568,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1568,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1569,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1569,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1569,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1569,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1570,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1571,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1572,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1572,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1573,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1573,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1574,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1574,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1574,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1574,4,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1574,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1575,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1575,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1575,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1576,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1576,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1576,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1576,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1576,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1577,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1577,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1577,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1578,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1578,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1578,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1579,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1579,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1579,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1580,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1580,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1580,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1580,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1580,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1581,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1581,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1582,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1582,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1582,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1582,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1582,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1583,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1583,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1583,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1583,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1583,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1583,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1584,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1584,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1584,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1585,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1585,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1585,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1586,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1586,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1586,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1586,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1587,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1587,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1587,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1587,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1587,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1588,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1588,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1588,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1588,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1589,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1589,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1589,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1589,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1590,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1590,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1590,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1590,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1591,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1591,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1592,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1592,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1592,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1593,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1593,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1593,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1594,1,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1595,1,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1595,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1596,1,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1597,1,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1597,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1598,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1599,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1600,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1601,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1602,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1602,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1602,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1602,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1603,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1603,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1603,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1603,4,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1604,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1604,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1604,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1604,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1605,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1605,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1605,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1605,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1606,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1606,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1606,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1606,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1606,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1607,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1607,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1607,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1607,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1607,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1607,6,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1608,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1608,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1609,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1609,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1609,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1610,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1610,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1610,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1610,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1610,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1611,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1611,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1611,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1612,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1612,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1612,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1612,4,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1613,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1613,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1613,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1613,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1613,5,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1614,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1614,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1614,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1614,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1615,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1615,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1615,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1615,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1615,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1615,6,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1616,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1616,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1616,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1616,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1617,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1617,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1617,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1617,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1617,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1618,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1618,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1618,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1618,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1619,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1619,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1619,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1619,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1619,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1619,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1620,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1620,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1620,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1621,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1621,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1622,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1622,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1622,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1622,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1622,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1622,6,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1623,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1623,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1623,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1624,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1624,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1624,3,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1624,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1625,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1626,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1627,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1628,1,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1629,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1629,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
1629,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1629,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1630,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1630,2,Headache,Headaches NEC,Headaches,Nerv,N
1630,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1630,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1630,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1630,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1630,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1630,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1631,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1632,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1632,2,Myelitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1632,3,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1632,4,Tuberculoma of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1632,5,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1633,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1634,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1635,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1636,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1637,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1637,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1637,3,Migraine,Migraine headaches,Headaches,Nerv,N
1637,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1638,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1639,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1640,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1640,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1640,3,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1640,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1641,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1642,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1642,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1642,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1642,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1643,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1643,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1644,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1645,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1646,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1646,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1647,1,Headache,Headaches NEC,Headaches,Nerv,N
1648,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1649,1,Drug clearance increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1649,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1650,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1650,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1650,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1651,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1651,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1651,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1651,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1652,1,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1652,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1653,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
